We are live on ! Find out more
Parallax Volatility Advisers

Parallax Volatility Advisers Portfolio holdings

AUM $58.9B
1-Year Est. Return 51.73%
This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+51.73%
3 Year Est. Return
+168.58%
5 Year Est. Return
+213.54%
10 Year Est. Return
+865.31%
AUM
$73.6B
AUM Growth
+$13B
Cap. Flow
+$743M
Cap. Flow %
1.01%
Top 10 Hldgs %
62.59%
Holding
5,549
New
2,351
Increased
689
Reduced
564
Closed
493

Sector Composition

Rank Sector Weight
1 Miscellaneous 95.88%
2 Financials 0.85%
3 Technology 0.73%
4 Consumer Discretionary 0.62%
5 Industrials 0.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLD
3226
DELISTED
Cloud Peak Energy Inc
CLD
$51K ﹤0.01%
+11,424
New +$48K
EBTC
3227
DELISTED
Enterprise Bancorp
EBTC
$50K ﹤0.01%
+1,470
New +$52.7K
ITIC
3228
Investors Title Co
ITIC
$563M
$50K ﹤0.01%
+252
New +$48.5K
PHX
3229
DELISTED
PHX Minerals
PHX
$50K ﹤0.01%
+2,436
New +$54.4K
SNDA icon
3230
Sonida Senior Living
SNDA
$1.9B
$50K ﹤0.01%
+249
New +$53.4K
XPRO icon
3231
Expro Ltd
XPRO
$2.04B
$50K ﹤0.01%
+1,260
New +$50.2K
TVRD
3232
Tvardi Therapeutics
TVRD
$24.7M
$50K ﹤0.01%
+113
New +$51.5K
EGIO
3233
DELISTED
Edgio, Inc. Common Stock
EGIO
$50K ﹤0.01%
+284
New +$56.1K
MRT
3234
DELISTED
MedEquities Realty Trust, Inc.
MRT
$50K ﹤0.01%
+4,494
New +$50.9K
BSRR icon
3235
Sierra Bancorp
BSRR
$523M
$49K ﹤0.01%
+1,848
New +$49.5K
CRMT icon
3236
America's Car Mart
CRMT
$12.3M
$49K ﹤0.01%
+1,092
New +$47.9K
ERII icon
3237
Energy Recovery
ERII
$377M
$49K ﹤0.01%
+5,544
New +$50.5K
KPTI icon
3238
Karyopharm Therapeutics
KPTI
$38.3M
$49K ﹤0.01%
+342
New +$54.9K
SHOE
3239
Shoe Station Group
SHOE
$351M
$49K ﹤0.01%
+3,696
New +$42.8K
VTGN icon
3240
VistaGen Therapeutics
VTGN
$10.5M
$49K ﹤0.01%
1,481
-7,714
-84% -$255K
RETA
3241
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$49K ﹤0.01%
+1,722
New +$48K
KDNY
3242
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$49K ﹤0.01%
+1,319
New +$57.6K
OXFD
3243
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$49K ﹤0.01%
+3,486
New +$51.1K
LTS
3244
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$49K ﹤0.01%
+15,624
New +$48.5K
ACET
3245
DELISTED
Aceto Corp
ACET
$49K ﹤0.01%
+4,704
New +$49.4K
ZOES
3246
DELISTED
Zoe's Kitchen, Inc.
ZOES
$49K ﹤0.01%
+2,940
New +$41.1K
PHH
3247
DELISTED
PHH Corporation
PHH
$49K ﹤0.01%
+4,788
New +$58.2K
ASPS icon
3248
Altisource Portfolio Solutions
ASPS
$64.6M
$48K ﹤0.01%
+215
New +$46K
BNED icon
3249
Barnes & Noble Education
BNED
$375M
$48K ﹤0.01%
+58
New +$38.3K
CRBP icon
3250
Corbus Pharmaceuticals
CRBP
$171M
$48K ﹤0.01%
+225
New +$48.2K

Similar funds

Parallax Volatility Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, Parallax Volatility Advisers held 5,549 positions worth $73.6B, up 21% from $60.6B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Parallax Volatility Advisers's Q4 2017 filing shows 2,351 new, 689 increased, 564 reduced and 493 closed positions. Its largest new stake was iShares MSCI Japan ETF: 520,841 shares worth $31.2M. The largest sale was iShares MSCI EAFE ETF, an estimated $227M.

By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, down from 97% a quarter earlier, followed by Financials and Technology.

  • Parallax Volatility Advisers's largest Q4 2017 buy was iShares MSCI Japan ETF: 520,841 shares worth $31.2M.
  • Parallax Volatility Advisers added most to iShares Russell 2000 ETF in Q4 2017, an estimated $118M increase.
  • Parallax Volatility Advisers's biggest Q4 2017 reduction was iShares MSCI EAFE ETF, cutting an estimated $227M.
  • Parallax Volatility Advisers fully exited Berkshire Hathaway Class A in Q4 2017, selling an estimated $19.5M.
  • Parallax Volatility Advisers's ten largest holdings make up 63% of its $73.6B portfolio in Q4 2017.
  • Parallax Volatility Advisers opened 2,351 new positions and closed 493 in Q4 2017.
  • Parallax Volatility Advisers's portfolio value rose 21% quarter-over-quarter to $73.6B.

Based on Parallax Volatility Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.